Adam Duerfeldt to Drug Discovery
This is a "connection" page, showing publications Adam Duerfeldt has written about Drug Discovery.
Connection Strength
0.355
-
Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases. Int J Mol Sci. 2020 Dec 04; 21(23).
Score: 0.182
-
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARa Agonists as Leads for Retinal Disorders. J Med Chem. 2020 03 26; 63(6):2854-2876.
Score: 0.173